Arkolith/Insider Trading/DMII/Form 4

Stockwell Lynn

CEO and Exe. Chair of Board, Director, 10% OwnerDrugs Made In America Acquisition II Corp. (DMII) · full profile →Form 4 · filed Oct 1, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 26, 2025Buy(P)700K——15.1M
Sep 26, 2025Sell(S)8.0M——6.7M
Sep 26, 2025Other(J)400K——14.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 26, 2025Buy(P)700K——700K

Transaction Codes

P
Open-market purchase
S
Open-market sale
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-25-094436) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML